Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

Volvo Cars will not pay Northvolt any money for its 50% stake in their battery venture Novo Energy that it had agreed to acquire, according to the automaker's quarterly report on Thursday.

Volvo Cars will pay Northvolt almost nothing for its 50% stake in their battery venture Novo Energy that it had agreed to acquire, according to the automaker's quarterly report on Thursday. Last week, ...

What’s going on here? Volvo gained full control of Novo Energy's battery project without any payment to Northvolt, following Northvolt's bankruptcy issues. Volvo strategically obtained a 50% stake in ...

Volvo Cars will not pay Northvolt any money for its 50% stake in their Novo Energy battery venture, which it had agreed to acquire, the automaker's quarterly report said on Thursday. The automaker ...

GOTHENBURG: Volvo Cars will not pay Northvolt any money for its 50% stake in their Novo Energy battery venture, which it had agreed to acquire, the automaker's quarterly report said on Thursday. The ...

Novo Nordisk shares rose after the drugmaker reported strong sales growth for its blockbuster obesity and diabetes drugs and issued a forecast for full-year 2025 results that topped analysts ...

With its Q4 2024 results on Wednesday, Novo Nordisk (NVO) announced a new Phase 3 trial to test its highly-anticipated weight loss therapy, CagriSema, after a December readout failed to meet ...

Novo Nordisk A/S today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn and a 26% rise in operating profit to ~$17.91bn for 2024. The company’s GLP-1 drugs, Ozempic ...

Novo Nordisk reported $40.5 billion in sales for 2024, surpassing Wall Street’s expectations. Its success was driven by its two GLP-1 drugs, Ozempic and Wegovy. The company is in a race with ...